The rapid development of social relations is currently leading to the transformation of many traditional legal tenets. Thus, public relations appear in the virtual space, cities can play a more significant role than the nation-state itself, and the design of the construction is often more expensive than the process of construction. These and many other things bring about the circumstances when the state, having its sovereignty, does not primarily take into account its territory to protect its own interests, as well as the emergence of new legal relations occurs without the usual binding to the territory. The purpose of this study is to assess the viability of the territory as one of the key characteristics of the state, taking into account the transformation of social relations under the modern conditions. The research attempts to understand the territory as a feature of the state with the latest trends in the development of social relations. To achieve this goal, modern scientific literature on the issue was analyzed to provide the assessment of the experience of new territory formation establishing new public relations and virtual space. It also provides an analysis of cross-border relations, carried out by both individuals and large commercial organizations. In order to develop an adequate legal doctrine, the methods of implementing the organizational and commercial activities of some organizations were investigated.

The development of a general concept of legal regulation of access storage processes and data protection of genome-wide sequencing in Russia should be based on the principles and laws formed not only at the level of international documents, but also the experience of leading countries in this field. In view of the fact that there are no completely identical national legal systems, the absence of universal recipes for the reception of certain legal institutions should be recognized. Analysis of the practical implementation of various approaches and legal techniques used to solve problems in this area will help to avoid mistakes and form key points for creating an optimal model of rational lawmaking, suggest approaches, methods and techniques of regulatory impact that can later be used in domestic legal system

The article examines the legal aspects of the functioning of the mechanism of prenatal diagnosis in Canada and the genetic testing procedure, accompanied by genetic counseling, taking into account the state structure, national, ethical and other distinctive features.

The article analyzes the features of legal regulation of genetic screening for prenatal diagnosis in the people’s Republic of China. The conducted research allowed to establish the main principles and regularities of the corresponding regulation. It is summarized that the leadership of the people’s Republic of China conducts a targeted policy for improving the health of the population, where one of the priorities is not to increase the population, but to improve the” quality “ of newborns (in the context of health). Realizing, in this regard, the positive possibilities of genetic screening in HDP in terms of improving the overall level of health of the population, the state is making a lot of efforts in the financial, legal, scientific, social and other spheres for its wide implementation in everyday clinical practice. Genetic screening when PND is free and available to alsegments of the population of China, it is part of health services financed by the state. These principles, as shown by the analysis of the legal framework for genetic screening in HDP, are system-forming in the framework of its legal regulation in the PRC. Currently, the main trend in the development of Chinese legislation in the field of genetic screening for HDP is more detailed regulation of various aspects of the use of this medical technology. China’s accumulated experience in legal regulation can be taken into account by the domestic legislator

The tendency to reduce the cost of genome sequencing observed in the last decade raises the question of the feasibility of investing in the healthcare system when integrating this technology into clinical practice. In addition, it is necessary to identify factors that will contribute to lower costs and stimulate additional investment in this area. It is also necessary to evaluate the cost-effectiveness of full-genome sequencing for diagnostic and pharmacogenomic applications